Form 4: Lantheus Holdings Director Mary Anne Heino Reports Stock Option Grant and Share Transactions

Sentiment:

SEC Form 4


Director Mary Anne Heino reports acquisition of shares and stock options in Lantheus Holdings, including transfers from a Grantor Retained Annuity Trust (GRAT).

Summary

  • On May 9, 2024, Mary Anne Heino, a director of Lantheus Holdings, Inc., reported transactions involving the company's stock.
  • Heino acquired 2,635 shares of common stock.
  • Heino was also granted stock options for 4,853 shares with an exercise price of $75.90, exercisable from May 9, 2025, to May 9, 2034.
  • Following these transactions, Heino directly owns 424,144 shares of common stock.
  • Heino also indirectly owns 78,980 shares and 130,134 shares through a Grantor Retained Annuity Trust (GRAT).

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a standard disclosure of insider transactions. The acquisition of shares and stock options could be interpreted as a positive sign, but it's not definitively bullish.

Positives

  • The acquisition of shares and stock options by a director could be seen as a positive signal, indicating confidence in the company's future performance.

Industry Context

This filing is a routine disclosure of insider transactions, which are common in publicly traded companies. These transactions are closely monitored by investors for insights into management's perspective on the company's value and future prospects.

Comparison to Industry Standards

  • Insider transactions are a normal part of corporate governance and are comparable to similar filings from directors and officers at other publicly traded companies such as GE Healthcare, Siemens Healthineers, and Philips.

Stakeholder Impact

  • The reported transactions may influence investor sentiment regarding Lantheus Holdings.

Key Dates

DateDescription
03/13/2024169,866 shares transferred from a Grantor Retained Annuity Trust (GRAT) to the Grantor.
05/09/2024Date of the reported transactions: acquisition of 2,635 shares and grant of stock options for 4,853 shares.
05/09/2025Earliest exercisable date for the stock options.
05/09/2034Expiration date for the stock options.
05/13/2024Date of signature for the Form 4 filing.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.